Case Report: Immobility-Induced Hypercalcemia in Infant

Share this content:
Case Report: Immobility-Induced Hypercalcemia in Infant
Case Report: Immobility-Induced Hypercalcemia in Infant

FRIDAY, March 18, 2016 (HealthDay News) -- A rare case of immobility-induced hypercalcemia in an infant has been documented in a case report published online March 18 in Pediatrics.

Neha Vyas, M.D., from the Rainbow Babies and Children's Hospital in Cleveland, and colleagues describe a case of an infant with hypercalcemia who presented with fatigue, irritability, and failure to thrive after prolonged immobilization.

The authors present the case of a 2-month-old female infant with a history of bladder exstrophy, an anteriorly displaced anus, and bilateral hip dysplasia who underwent reconstruction of her midline structures on day 11 of life. She was placed in a hip spica cast from day 11 to day 42, and was noted to have increased irritability after removal of the cast. On day 53, she presented to the emergency department with visible signs of fatigue, irritability, and failure to regain birth weight. Hypercalcemia was revealed on laboratory evaluation. The patient was managed with intravenous hydration and switched from exclusive breastfeeding to a low-calcium, vitamin D-free formula, and after not tolerating the switch was changed to breastfeeding with Similac Sensitive formula supplementation. Resolution of the hypercalcemia occurred at day three of hospitalization. After showing stable calcium levels and steady weight gain the patient was discharged on day 12 of hospitalization.

"This case highlights the importance of including this rare entity in a differential diagnosis of hypercalcemia as well as screening postsurgical patients with prolonged immobility for hypercalcemia," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »